What Researchers Did
Researchers evaluated the efficacy of hyperbaric oxygen therapy (HBOT) as an adjunctive treatment for 45 patients with mutilated hand injuries after reconstruction or revascularization.
What They Found
The study included 45 patients (38 men, 7 women) with an average age of 37.2 years (range 18-62). The mean defect area among these patients was 131.5 cm.
What This Means for Canadian Patients
If hyperbaric oxygen therapy proves effective, it could offer Canadian patients with severe hand injuries an additional treatment option to improve limb survival and reduce complications. This adjunctive therapy might enhance recovery and functional outcomes following reconstructive surgery for such complex injuries.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
A potential limitation of this study is the absence of a control group, which makes it difficult to definitively attribute outcomes solely to HBOT.